Insiders who reported open-market trades in the last 12 months at the companies Thomas Trimarchi files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Neil Kumar - $45.20M in BBIO purchases and sales in the last 12 months
Jennifer E. Cook - $21.92M in BBIO purchases and sales in the last 12 months
Frank McCormick - $13.31M in BBIO purchases and sales in the last 12 months
Andrew Lo - $6.32M in BBIO purchases and sales in the last 12 months
Andrea Ellis - $5.65M in BBIO purchases and sales in the last 12 months
Hannah Valantine - $4.37M in BBIO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Thomas Trimarchi is a corporate insider, tracked as President and CFO of BridgeBio Pharma, Inc. (BBIO). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Thomas Trimarchi submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Thomas Trimarchi been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($5.99M) across all tracked filings.
Thomas Trimarchi is President and CFO of BridgeBio Pharma, Inc. (BBIO). 10 SEC Form 4 filings on record going back to 2024, most recently on 18 August 2026. Most recent open-market trade: sold $211K of BBIO on 19 May 2026. Lifetime open-market sales: $5.99M.
Recent transactions
18
The latest 18 SEC Form 4 transactions reported by Thomas Trimarchi.
InsiderAlpha's records for Thomas Trimarchi go back to 2024: 10 primary Form 4 filings, an average of 3.3 per year. 9 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
